The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A comparative study of blood-based KRAS mutation analysis in circulating tumor cells versus circulating plasma DNA to predict primary tumor mutations in lung cancer.
Eric Kian Saik Lim
No relevant relationships to disclose
Maxim B Freidin
No relevant relationships to disclose
Dasha V Freydina
No relevant relationships to disclose
Dimple Chudasama
No relevant relationships to disclose
Maria Leung
No relevant relationships to disclose
Sanjay Popat
No relevant relationships to disclose
David Gonzalez de Castro
No relevant relationships to disclose
Alexandra Rice
No relevant relationships to disclose
Vladimir Anikin
No relevant relationships to disclose
Angeles Montero Fernandez
No relevant relationships to disclose
Andrew G Nicholson
No relevant relationships to disclose